AMIVAS (US), LLC

ARTESUNATE

Manufacturer:

AMIVAS (US), LLC

Artesunate HCPCS:

J0391

HCPCS Code Descriptor:

Injection, artesunate, 1 mg

Category:

J Code

Artesunate NDCs:

73607-0011-11

Primary Type:

Antimalarial

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

73607-0011-11

About Artesunate:

ARTESUNATE is a Antimalarial drug manufactured by AMIVAS (US), LLC and administered via the Intravenous route of administration. The J Code: J0391 is aligned to the drug ARTESUNATE.

Artesunate is used to treat severe malaria in both adults and children. It belongs to a class of drugs called antimalarials. Malaria is a red blood cell infection that is transmitted by the bite of a mosquito. Artesunate can be used alone, or as part of a combination therapy with other drugs, such as mefloquine.

ACCESS PRICING AND MORE BY REGISTERING

J0391 Added Date:

January 1, 2024

J0391 Effective Date:

January 1, 2024

J0391 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Artesunate billing and coding information.
Our team did not identify a source for Artesunate patient assistance information. Please reach out to our team if you feel that this is a mistake.
ARTESUNATE prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ARTESUNATE. Please check back in a few weeks.